CrushSCI.com
117.1Average days
127Median days
12Fastest days
219Longest days
3102025 publications

Paper Review Records

All Paper Review Records

14 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

60 days

A contract research organization perspective on secondary pharmacology: current practices, panel selection, and emerging needs for interpretation

Authors
Emilie Desfosses; Stéphanie A.D. Bonnet; Thierry JolasShow moreShow less
Affiliations
Eurofins Discovery, 2 rue du Professeur Gargouïl, BP30001, 86600 Celle-Lévescault, FranceShow moreShow less
Source PDF DOI Publisher page
48 days

Integration of safety pharmacology endpoints into toxicology studies - A survey of GLP institutions in China

Authors
Bin Zhao; Chen Wang; Na Zhang; Ailing Zeng; Yaqin Peng; Wenqiang Zhang; Xuewu Liu; Jean-Pierre Valentin; Jennifer Pierson; Michael K. Pugsley; Jufeng WangShow moreShow less
Affiliations
West China-Frontier PharmaTech Co., Ltd., Chengdu, China; Triapex Laboratory Co., Ltd., Nanjing, China; Pharmaron Beijing Co., Ltd., Beijing, China; College of Public Health, Sichuan University, Chengdu, China; Guangdong Lewwin Pharmaceutical Research Institute Co. Ltd., Guangdong, China; Hunan Prima Drug Research Center Co., Ltd., Changsha, China; UCB, Braine l'Alleud, Belgium; Health and Environmental Sciences Institute (HESI), Washington, DC, United States of America; Cytokinetics LLC., South San Francisco, CA, United States of AmericaShow moreShow less
Source PDF DOI Publisher page
34 days

Weight of evidence in safety pharmacology guidance: A case for explicit probabilistic reasoning in the revision of ICH S7A

Authors
Derek J. Leishman; Michael K. Pugsley; Christopher P. Regan; Sridharan Rajamani; Michael G. Rolf; Eric I. Rossman; Jean-Pierre Valentin; Todd A. Wisialowski; Jill V. Nichols; Hugo M. VargasShow moreShow less
Affiliations
Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, United States of America; Cytokinetics, Toxicology & Safety Pharmacology, South San Francisco, CA, United States of America; Safety & Exploratory Pharmacology, Merck & Co., Inc., Rahway, NJ, United States of America; Johnson & Johnson Innovative Medicine, 3120 Merryfield Row, San Diego, CA 92121, United States of America; AstraZeneca R&D, Pepparedsleden 1, 431 83, Mölndal, Sweden; Labcorp Early Development Laboratories Inc., Madison, WI 53704, United States of America; Early Clinical Development & Translational Science, UCB, Braine-l'Alleud, Belgium; Pfizer Research and Development, Safety Pharmacology, Groton, CT 06340, United States of America; Amgen, Inc, Translational Safety & Risk Sciences, Thousand Oaks, CA, United States of AmericaShow moreShow less
Source PDF DOI Publisher page
219 days

Impact of filter selection on UPLC quantification of terbinafine hydrochloride: Optimization of sample preparation and method validation

Authors
Giovanna Pereira Peressoni; Nicolly Bittencourt Guedes; Izabelle Amorim Ferreira Boza; Giovana Carolina Bazzo; Hellen Karine StulzerShow moreShow less
Affiliations
Department of Chemistry, Center for Physical and Mathematical Sciences, Federal University of Santa Catarina, 88040-900 Florianópolis, SC, Brazil; Department of Pharmaceutical Sciences, Federal University of Santa Catarina, 88040-900 Florianópolis, SC, BrazilShow moreShow less
Source PDF DOI Publisher page
194 days

Development of spectroscopic methods using charge transfer complex for the quantitative estimation of proguanil hydrochloride: Insights from greenness evaluation, BSA binding, molecular docking, antimicrobial studies and Insilico toxicity assessment

Authors
Abdullah Mannan; Adila Khalil; Mohammad Kashif; Aliya FirdausShow moreShow less
Affiliations
Analytical Chemistry Section, Department of Chemistry, Aligarh Muslim University, Aligarh, (U.P.) 202002, India; Bio-control Research Laboratory, Integral University, Kursi Road, Lucknow, (U.P.) 226026, IndiaShow moreShow less
Source PDF DOI Publisher page
12 days

Advancing safety pharmacology: Emerging technologies, innovative methods, and future directions

Authors
Michael K. Pugsley; Brett R. Winters; Lutfiya Miller; Simon Authier; Michael J. CurtisShow moreShow less
Affiliations
Toxicology & Safety Pharmacology, Cytokinetics, South San Francisco, CA 94080, USA; 3rdAI LLC, Birmingham, AL, USA; Charles River Laboratories, Laval, QC H7V 4B3, Canada; Cardiovascular Division, King's College London, Rayne Institute, St Thomas' Hospital, London SE17EH, UKShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS take to review a manuscript?

As of 2026-11-19, CrushSCI has 14 complete review records for JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS. The fastest paper went from submission to acceptance in 12 days (Advancing safety pharmacology: Emerging technologies, innovative methods, and future directions, received 2026-07-16, accepted 2026-07-28); the slowest took 219 days. The average is 117.1 days and the median is 127 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.